• Andriole G et al. Treatment with Finasteride following radical prostatectomy for prostate cáncer. Urology 45:491-497, 1995
• Andriole G, Bostwick D, Civantos F et al. The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cáncer: current state of knowledge. J Urol. 174(6):2098-2104, Dec 2005
• Aoki A, Naito K, Hashimoto O et al.Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasía in a multicentered study. Hinyokika Kiyo. 48(5):259-267, May 2002
• Arnot B. The Prostate Cáncer Protection Plan. Little Brown and Company Edit.2000
• Armstrong B, Doll R. Environmental factors and cáncer incidence and mortality in different countries, with special reference to dietary practices. International Journal of Cáncer 15(4): 617-631, 1975.
• Aronson K et al. Dietary Pattern May Increase Prostate Cáncer Risk. Int J Cáncer 116:592-598, 2005
• Asplund R et al. Diurnal variation in the levels of antidiuretic hormone in the elderly.J Int Med 229:131-4, 1999
• Asplund R, Aberg H. Desmopressin in elderly subjects with uncreased nocturnal diuresis: a two-month treatment study. Scand J Urol Nephrol 27:77-82,1993
• Attar-Bashi N et al. Alpha-linolenic acid and the risk of prostate cáncer. What is the evidence?. J Urol 171:1402-1407, April 2004
• Aus G, Abbou C, Bolla A et al. Guidelines on Prostate Cáncer. EAU 2006, 3.Risk Factors :8.
• Austoker J. Cáncer prevention in primary care. Diet and cáncer. BMJ 308:1610-1614, 1994
• Awad A, Burr A, Fink C. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. Prostaglandins Leukot Essent Fatty Acids. 72(3):219-226, Mar 2005
• Bairati I, Meyer F, Fradet Y. Dietary fat and advanced prostate cáncer. J Urol 159(4): 1271-1275, 1998.
• Balkwill F, Mantovani A. Inflammation and cáncer: back to Virchow? Lancet 357:539,2001
• Baretton G et al. Comparison of DNA ploidy in prostatic intraepithelial neoplasía and invasíve carcinoma of the prostate: an image cytometric study. Hum Pathol 25: 506-513,1994
• Barham J, Edens M, Fonteh A et al. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 130(8):1925-1931, Aug 2000
• Barlet A et al. Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasía: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study. Wien Klin Wochenschr. 102(22):667-673, 23 Nov 1990
• Barqawi A et al. Prostate cáncer chemoprevention:an overview of United States Trials. J Urol 171(2) part 2 of 2: S5-S9, Feb 2004.
• Barnes S, Peterson T, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for bread and prostate cáncer. J Cell Biochem Suppl 22:181-187, 1995
• Barnes S: Effect of genistein on in vitro and in vivo models of cáncer. J Nutr 125(3 Suppl) :777S-783S,1995
• Barsanti J et al. Effects of an extract of Serenoa repens on dogs with hyperplasía of the prostate gland. Am J Vet Res 61:880-885, Aug 2000
• Barry M, Roehrborn C. Medical Management of Benign prostatic obstruction Ch 18 in Office Urology. The Clinician´s Guide. edited by ED Kursh and JC Ulchaker. Humana Press Inc 2001.
• Basch C. 5-A-Day dietary behavior and the fruit and vegetable intake of Latino children. Arch Ped Adolesc Med 150:81-86, 1996
• Bassler J, Piazza G. Nonesteroidal anti-inflamatory drugs and cyclooxygenase-2 selective inhibitors for prostate cáncer chemoprevention. J Urol 171(2) part 2 of 2: S59-S63, Feb 2004.
• Bassi P, Artibani W, De Luca V, et al. Standardized extract of Pygeum africanumin the treatment of benign prostatic hypertrophy. Controlled clinical study versus placebo. Minerva Urol Nefrol. 39:45–50, 1987
• Belaiche P. Clinical studies on the palliative treatment of prostatic adenoma with extract of Urtica root. Phyt Res 5:267-69, 1991
• Bent S, Kane C, Shinohara K et al. Saw Palmetto for benign prostatic hyperplasía. New England J Med 354:557-566, 2006
• Beebe-Dimmer J, Wood Jr D et al. Use of complementary and alternative medicine in men with family history of prostate cáncer: a pilot sudy. Urology 63 (2):282-287,Feb 2004
• Benning CM, Kyprianou N.Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cáncer cell apoptosis via an alpha1-adrenoceptor-independent action. Cáncer Res 62(2):597-602, 15 Jan 2002
• Berenguer A. Polyphenols in red wine induce apoptosis of prostate cáncer cells. BJU Int 89:550-554,2002
• Berges R, Kassen A, Senge T. Treatment of symptomatic benign prostatic hyperplasía with beta-sitosterol: an 18-month follow-up. BJU Int. 85(7):842–846, 2000
• Berges R, Windeler J, Trampisch H, et al. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasía. Beta-sitosterol Study Group. Lancet 1995;345:1529 – 1532
• Berndt S, Ballentine Carter H, et al. Calcium intake and prostate cáncer risk in a long-term aging study: The Baltimore Longitudinal Study of Aging. Urology 60(6): 1118-1123, Dec 2002.
• Berry S.The development of human benign prostatic hyperplasía with age. J Urol 132:474-479,1984
• Beta Carotene Cáncer Prevention Study Group The Alpha-Tocopherol. The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cáncer and Other Cáncers in Male Smokers. New England Journal of Medicine 330 (15):1029-1035, 14 April 1994.
• Bettuzzi S, Brausi M, Rizzi F et al. Chemoprevention of human prostate cáncer (PCA) by oral administration of green tea catechins
• (GTCs) in high-grade PIN (GHPIN) subjetct: a preliminary report from a 1 year proof-of-principle study. Abstracts # 576 Eur Urol Suppl 2006;
• 5(2):166 and Cáncer Res 66:1234-1240, 2006
• Berndt S et al. Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cáncer. Nutrit 21(6):686-690, Jun 2005
• Biasco G. European Trials on Dietary Supplementation for Cáncer Prevention. Annals New York Acad of Scienc 889:152-56, 1999
• Bingham S, Atkinson C, Liggins J, et al. Phytooestrogens: Where are we now? Br J Nutr. 79:393-406, 1998
• Bingham S.Diet and cáncer–the European Prospective Investigation into Cáncer and Nutrition.Nat.Rev.Cáncer 4(3),206-215, 2004
• Birt D et al.Dietary agents in cáncer prevention:Flavonoids and isoflavonoids Pharmacol and Therapeutics, 90:2-3:157-177, 2001
• Blaivas J. Overactive Bladder revisited. Neurourol Urodyn 21:523,2002
• Block K. Nutritional Oncology and Integrative Cáncer Care. A rational mechanism-based approach. pp 618-636. Complementary &
• Alternative Medicine. Novey DW. Mosby 2000.
• Block G et al. Fruit, vegetables, and cáncer prevention: A review of the epidemiological evidence. Nutr Cáncer 18:1-29, 1992 Blot W et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cáncer
• incidence, and disease-specific mortality in the general population. Journal of the National Cáncer Institute 85(18): 1483-1492, 1993 Blumenfeld A et al. Nutritional aspects of prostate cáncer: a review. Can J Urol. 7(1):927-935, Feb 2000 Blumenthal M. The complete German commission E monographs. Therapeutic guide to herbal medicines. Newton Máss 1999
• Integrative Medicine Communications
• Blumenthal M. "ConsumerLab.com tests ginkgo and saw palmetto products," Herbalgram 48:66,2000
• Blumenthal, M, Goldberg, A, Brinckman, J, eds. Saw palmetto berry. Herbal Medicine: Expanded Commission E Monographs.
• Newton MA: Lippincott Williams & Wilkins; 335-340, 2000
• Boffetta P. Methodological aspects of the epidemiological association between cadmium and cáncer in humans. In Nordberg G,
• Herber R, Alessio L, eds.Cadmium in the Human Environment. Toxicity and Carcinogenicity. France: Intern Ag for Res Cáncer, 425-34, 1992 Bogani P, Visioli F. Antioxidants in the Mediterranean diets: An update. World Rev Nutr Diet. 2007;97:162-79 Bonham M, Galkin A, Montgomery B et al.Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated
• prostate tumor growth inhibition. J Natl Cáncer Inst. 94(21):1641-1647, 6 Nov 2002
• Bonjour J, Chevalley T, Fardellone P. Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate
• cáncer. Br J Nutr. 97(4):611-616, april 2007
• Bonkhoff H, Stein U, Welter C et al. Differential expression of the pS2 protein in the human prostate and prostate cáncer:
• association with premalignant changes and neuroendocrine differentiation. Hum Pathol 26(8): 824-8 Aug 1995
• Boon H, Westlake K et al. Use de complementary/alternative medicine (CAM) by men diagnosed prostate cáncer: Prevalence and
• characteristics. Urology 62(5):849-853, Nov 2003.
• Borins M. The dangers of using herbs. What your patients need to know. Postgrad Med 104(1):91-100,1998
• Bosetti C et al .Flavonoids and Prostate Cáncer Risk: A Study in Italy. Nutrition and Cáncer 56(2):123-127,2006
• Bostrom K. Chronic inflammation of the male accessory sex glands and its affect on the morphology of the spermatozoa. Scand J
• Urol Nephrol 5:133, 1971